Ginkgo Bioworks Holdings, Inc. (DNA) › Capital ExpendituresGinkgo Bioworks Holdings, Inc. (DNA) — Capital ExpendituresAnnual figures by fiscal year, from SEC filings.2019: $22.22M2020: $57.82M2021: $56.52M2022: $52.27M2023: $40.80M2024: $62.54M2025: $7.67M$7.67M2019Capital Expenditures (USD)2025Fiscal YearCapital ExpendituresChange YoY2025$7.67M-87.7%2024$62.54M+53.3%2023$40.80M-21.9%2022$52.27M-7.5%2021$56.52M-2.2%2020$57.82M+160.2%2019$22.22M—Other metrics: RevenueCost of RevenueGross ProfitOperating IncomeNet IncomeEPS (Diluted)Total AssetsTotal LiabilitiesShareholders' EquityCash & EquivalentsOperating Cash FlowShares OutstandingDividends Per Share